InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Cochran John, Director. Director active across 1 companies, notably Aquestive Therapeutics, Inc.. Aggregated, 2 disclosures have been logged. The latest transaction was filed on 10 May 2021 — Don. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
037,500 shares0
Common Stock
SEC:0001214659-21-006162·
037,500 shares0
Common Stock
SEC:0001214659-21-006162:0·
2 of 2 declarations
About Cochran John
John Cochran is a Director at Aquestive Therapeutics, Inc. In this role, he participates in the governance and strategy of the company. Aquestive Therapeutics, Inc. is a biopharmaceutical company specializing in developing innovative treatments. John Cochran brings his expertise in the health sector to help guide strategic decisions.
